M
MAZE
Maze Therapeutics
29.00
+0.29+1.01%After Hours: 29.50 +0.50 +1.72%18:51 04/06 EDT
OPEN/PREV CLOSE29.38/28.33
TODAY RANGE27.85-29.50
VOL926.84K
MARKET CAP1.40B
52 WEEK RANGE6.71-53.65
AVG VOL (3M)742.16K
% TURNOVER1.86%
TURNOVER--
P/E (TTM)-9.2068
% RANGE5.82%
EPS(TTM)-3.0510
P/E(FORWARD)-10.0335
P/B3.904
BVPS7.19
DIVIDEND--
P/S8.29
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.23B
SHARES OUTSTANDING49.71M
NEXT EARNINGS05/11-05/18
FREE FLOAT43.63M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Dow Jones·03/31 16:22
Maze Therapeutics Price Target Raised to $58.00/Share From $52.00 by JP Morgan
Dow Jones·03/31 16:22
Maze Therapeutics Is Maintained at Overweight by JP Morgan
Benzinga·03/31 16:12
JP Morgan Maintains Overweight on Maze Therapeutics, Raises Price Target to $58
TipRanks·03/31 10:59
J.P. Morgan Sticks to Its Buy Rating for Maze Therapeutics, Inc. (MAZE)
TipRanks·03/31 10:51
Maze Therapeutics price target raised to $58 from $52 at JPMorgan
Reuters·03/31 07:39
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
TipRanks·03/31 02:15
Maze Therapeutics, Inc. (MAZE) Gets a Buy from Mizuho Securities
TipRanks·03/28 14:37
Maze Therapeutics, Inc. (MAZE) Gets a Buy from LifeSci Capital
Seeking Alpha·03/27 19:09
Maze Therapeutics: MZE829 Presses Forward Despite Stock Price Drop
Same Industry
Name/Symbol
Change%
Price